SC 13G/A: COMMUNITY HEALTH SYSTEMS INC

AI Summary

SC 13G/A filing by COMMUNITY HEALTH SYSTEMS INC.

Risk Assessment

Risk Level: low

FAQ

Key Financial Figures

• $0.01 — ame of Issuer) Common Stock, par value $0.01 per share (Title of Class of Securitie

Filing Documents

• cyh25240sc13ga2.htm (SC 13G/A) — 93KB
• 0001214659-24-002724.txt ( ) — 96KB

If this statement is filed pursuant to §§240.13d-1(b)

Item 3. If this statement is filed pursuant to §§240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a: (a) ¨ Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o). (b) ¨ Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c). (c) ¨ Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c). (d) ¨ Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8). (e) x An investment adviser in accordance with §240.13d-1(b)(1)(ii)(E); (f) ¨ An employee benefit plan or endowment fund in accordance with §240.13d-1(b)(1)(ii)(F); (g) ¨ A parent holding company or control person in accordance with §240.13d-1(b)(1)(ii)(G); (h) ¨ A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813); (i) ¨ A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3); (j) ¨ Group, in accordance with §240.13d-1(b)(1)(ii)(J).

Ownership

Item 4. Ownership. Provide the following information regarding the aggregate number and percentage of the class of securities of the issuer identified in Item 1. (a) Amount beneficially owned: 7,231,126 (b) Percent of class: 5.3%** (c) Number of shares as to which the person has: (i) Sole power to vote or to direct the vote 6,981,795 (ii) Shared power to vote or to direct the vote 249,331* (iii) Sole power to dispose or to direct the disposition of 6,981,795 (iv) Shared power to dispose or to direct the disposition of 249,331* * Note: As of the close of business on December 31, 2023, Eversept and its controlling persons beneficially owned 7,231,126 Shares, including 249,331 Shares held in Eversept’s Managed Accounts. ** Note: As of December 31, 2023, Eversept and its controlling persons were the beneficial owners of approximately 5.3% of the outstanding Shares, based on 136,800,913 shares of Common Stock of the Issuer outstanding as of October 20, 2023, as reported in the Issuer’s Form 10-Q filed on October 26, 2023, including 0.2% of the outstanding Shares held in Eversept’s Managed Accounts. Instruction . For computations regarding securities which represent a right to acquire an underlying security see §240.13d-3(d)(1).

Ownership of Five Percent or Less of a Class

Item 5. Ownership of Five Percent or Less of a Class. If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than five percent of the class of securities, check the following ¨ . CUSIP No. 203668108 13G Page 9 of 10 Pages Instruction . Dissolution of a group requires a response to this item.

Ownership of More than Five Percent on Behalf of Another Person

Item 6. Ownership of More than Five Percent on Behalf of Another Person. Not applicable.

Identification and Classification of the Subsidiary Which Acquired

Item 7. Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on By the Parent Holding Company. Not applicable.

Identification and Classification of Members of the Group

Item 8. Identification and Classification of Members of the Group. Not applicable.

Notice of Dissolution of Group

Item 9. Notice of Dissolution of Group. Not applicable.

Certification

Item 10. Certification. By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect. Exhibits Exhibit A - Joint Filing Agreement CUSIP No. 203668108 13G Page 10 of 10 Pages After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct. February 14, 2024 Date EVERSEPT PARTNERS, L.P. By: /s/ Kamran Moghtaderi Managing Principal EVERSEPT GP, LLC By: /s/ Kamran Moghtaderi Managing Member EVERSEPT GLOBAL HEALTHCARE FUND, LP By: Eversept GP, LLC Its: General Partner By: /s/ Kamran Moghtaderi Managing Member EVERSEPT 1 LLC By: /s/ Kamran Moghtaderi Managing Member KAMRAN MOGHTADERI /s/ Kamran Moghtaderi Exhibit A AGREEMENT REGARDING JOINT FILING OF STATEMENT ON SCHEDULE 13D OR 13G The undersigned agree to file jointly with the Securities and Exchange Commission (the "SEC") any and all statements on Schedule 13D or Schedule 13G (and any amendments or supplements thereto) required under section 13(d) of the Securities Exchange Act of 1934, as amended, in connection with purchases by the undersigned of the securities of any issuer. For that purpose, each of the undersigned hereby constitutes and appoints Eversept Partners, L.P., a Delaware limited partnership, as its true and lawful agent and attorney-in-fact, with full power and authority for and on behalf of the undersigned to prepare or cause to be prepared, sign, file with the SEC and furnish to any other person all certificates, instruments, agreements and documents necessary to comply with section 13(d) and section 16(a) of the Securities Exchang

View Full Filing

View this SC 13G/A filing on SEC EDGAR